Diagnostic Accuracy Study of Indocyanine Green for Perfusion Assessment

计划入组 80 人 · 首次发布于 2024 年 8 月 30 日

Diagnostic Accuracy Study of Indocyanine Green for Parathyroid Perfusion Assessment

计划入组 10 人 · 首次发布于 2019 年 5 月 31 日

The Use of Indocyanine Green as a Diagnostic Adjunct for Pediatric Solid Malignancies

计划入组 45 人 · 首次发布于 2020 年 7 月 30 日

Diagnostic T320

Brilliant green

C₂₇H₃₃N₂

Light green SF yellowish

C₃₇H₃₄N₂Na₂O₉S₃

ORI DIAGNOSTIC INSTRUMENTS, LLC

United States

NEURO-EYE DIAGNOSTIC SYSTEMS, LLC

United States

GREEN CROSS CORPORATION

India

Zydus Lifesciences Wins USFDA Approval for Generic Indocyanine Green Injection with Competitive Generic Therapy Designation

Travere Therapeutics Pauses Enrollment in Phase 3 Homocystinuria Trial Due to Manufacturing Issues

MAIA Biotechnology's THIO Shows Promise in Phase II Lung Cancer Trial; Institutional Investment Increases